drug-induced hepatotoxicity. Toxic liver disease, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients are treated with jujube-based syrup for a month receiving 10 cc of the syrup two times a day, fasting morning and half an hour before bedtime. Routine anti
Sponsors
Sari University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Declaration of written consent of the volunteer for participation in the trial Age from 30 to 65 years A new diagnosis of pulmonary tuberculosis by an infectious disease specialist or a health center doctor No relapse or drug resistance No history of HIV-positive No history of renal failure No history of all types of acute and chronic and alcoholic hepatitis No history of cirrhosis No Pregnancy and lactation
Exclusion criteria
Exclusion criteria: Patients under treatment with other herbal supplements Lack of appropriate verbal communication Patients with Oral intolerance No tendency to take herbal medicine No tendency to consume syrup
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum level of alanine aminotransferase. Timepoint: At the beginning of the study (before the intervention),The end of the second week and at the end of the intervention. Method of measurement: Biochemical tests.;Serum level of aspartate aminotransferase. Timepoint: At the beginning of the study (before the intervention),The end of the second week and at the end of the intervention. Method of measurement: Biochemical tests.;Serum level of Alkalin phosphatase. Timepoint: At the beginning of the study (before the intervention),The end of the second week and at the end of the intervention. Method of measurement: Biochemical tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAssie Jokar
Sari University of Medical Sciences
Outcome results
None listed